Sudarshan Pharma Industries share news, announcements and annual reports
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹37.48.
30 Oct: open ₹39.04, high ₹39.29, low ₹34.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹927 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 1.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,84,31446.6% delivered
Sudarshan Pharma Industries has 248 announcements on record, routine notices left out; 7 in the 30 days to 31 Oct 2026, the latest on 30 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Sudarshan Pharma Industries quarterly results
The board met on 29 Oct 2026 to consider half yearly results, issue of warrants, financial results and fund raising
Notice filed 26 Oct 2026
Sudarshan Pharma Industries annual reports, presentations and earnings calls
The company's own documents, latest first.Sudarshan Pharma Industries financials, year by year
Annual reports4
- Annual report, year to Mar 202629 Aug 2026
- Annual report, year to Mar 20251 Jul 2025
- Annual report, year to Mar 20245 Sep 2024
- Annual report, year to Mar 202310 Aug 2023
Investor presentations7
- We hereby submit the updated Investor Presentation18 Aug 2026
- We hereby submit the presentation on the manufacturing plant proposed to be acquired by the Company.14 Aug 2026
- Interms of Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we submit the Investor Presentation of the Company.31 Jan 2026
- Please find attached the updated Investor Presentation.14 Aug 2025
- Investor Presentation as on June, 202420 Jul 2024
Sudarshan Pharma Industries share news and announcements
Newest first. Page 1 of 5.
Oct 2026
30 Oct
23 Oct · Updates On Migration From SME Platform Of BSE To Capital Market Segment (Main Board) Of National Stock Exchange Of India Limited Of Sudarshan Pharma Industries Limited - Company Letter Bearing Ref. No. SPIL/CS/SE/2026-2027/20 Dated 21St May 2026
Sep 2026
22 Sep · Meeting
Aug 2026
29 Aug · Reg. 34 (1) Annual Report.
19 Aug · Announcement under Regulation 30 (LODR)-Allotment
14 Aug · FCCB Committee Meeting On Wednesday, 19-August-2026
10 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
Jun 2026
15 Jun · Board meeting
Meeting on 18 Jun 2026: issue of warrants12 Jun · Announcement under Regulation 30 (LODR)-Allotment
11 Jun · Meeting Of Warrants Committee Of The Company Scheduled On Thursday, 11/June/2026 Now Postponed To Friday, 12/June/2026
8 Jun · Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026
May 2026
21 May · Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities.
21 May · Announcement under Regulation 30 (LODR)-Allotment
18 May · Board meeting
Meeting on 21 May 202618 May · Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Announcement Dated 15/05/2026
15 May · Analysts
How the price met the news
The first session after each announcement, beside the market. Moves to 11 May 2026 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 11 May 2026Board or managers changeddown 0.66%+0.7 pts vs Nifty 500market median 0.0% · five sessions −0.9% (+1.6 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 4 May 2026Board or managers changedup 2.41%+1.8 pts vs Nifty 500market median 0.0% · five sessions +0.1% (−1.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 3 Dec 2025Board or managers changeddown 3.41%−3.0 pts vs Nifty 500market median 0.0% · five sessions −7.6% (−6.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 19 Aug 2025Board or managers changedup 2.78%+2.2 pts vs Nifty 500market median 0.0% · five sessions +6.6% (+6.1 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 18 Aug 2025Board or managers changedup 2.96%+1.9 pts vs Nifty 500market median 0.0% · five sessions +11.9% (+10.6 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 6 Aug 2025Board or managers changeddown 1.05%−0.5 pts vs Nifty 500market median 0.0% · five sessions −0.5% (+0.5 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 7 Mar 2025Board or managers changedup 0.31%+0.3 pts vs Nifty 500market median 0.0% · five sessions −9.1% (−7.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 2 Dec 2024Board or managers changedup 0.82%+0.2 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−4.0 pts vs Nifty 500) · volume 3.0× usual · The announcement
- 28 May 2024Board or managers changeddown 6.63%−6.1 pts vs Nifty 500market median 0.0% · five sessions −8.8% (−3.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 2 Apr 2024Board or managers changedup 1.71%+1.3 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−1.3 pts vs Nifty 500) · volume 0.7× usual · The announcement
8 earlier announcements
- 13 Dec 2023Board or managers changedup 2.49%+2.1 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−2.6 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 12 Nov 2023Board or managers changeddown 4.67%−5.3 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−4.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 18 Sep 2023Board or managers changedup 3.87%+4.2 pts vs Nifty 500market median 0.0% · five sessions +2.2% (+4.4 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 11 Aug 2023Dividendup 2.77%+3.2 pts vs Nifty 500market median 0.0% · five sessions +10.6% (+11.7 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 24 Jul 2023Board or managers changedup 2.32%+3.4 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+4.1 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 24 Jul 2023Dividendup 2.32%+3.4 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+4.1 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 20 Jun 2023Board or managers changedup 0.44%+0.1 pts vs Nifty 500market median 0.0% · five sessions −4.6% (−4.1 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 29 May 2023Dividendup 5.34%+4.9 pts vs Nifty 500market median 0.0% · five sessions +2.3% (+1.6 pts vs Nifty 500) · volume 0.8× usual · The announcement
Sudarshan Pharma Industries results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.